These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

689 related items for PubMed ID: 3698020

  • 1. Resistance to adriamycin: relationship of cytotoxicity to drug uptake and DNA single- and double-strand breakage in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.
    Goldenberg GJ, Wang H, Blair GW.
    Cancer Res; 1986 Jun; 46(6):2978-83. PubMed ID: 3698020
    [Abstract] [Full Text] [Related]

  • 2. Multifactorial resistance to adriamycin: relationship of DNA repair, glutathione transferase activity, drug efflux, and P-glycoprotein in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.
    Deffie AM, Alam T, Seneviratne C, Beenken SW, Batra JK, Shea TC, Henner WD, Goldenberg GJ.
    Cancer Res; 1988 Jul 01; 48(13):3595-602. PubMed ID: 2897875
    [Abstract] [Full Text] [Related]

  • 3. Enhancement of adriamycin-induced cytotoxicity by increasing retention and inhibition of DNA repair in DOX-resistant P388 cell lines with new calcium channel blocker, DMDP.
    Bankusli I, Yin MB, Mazzoni A, Abdellah AJ, Rustum YM.
    Anticancer Res; 1989 Jul 01; 9(3):567-74. PubMed ID: 2764503
    [Abstract] [Full Text] [Related]

  • 4. Adriamycin-induced DNA strand breaks in HeLa and in P388 leukaemia cells detected using in situ nick translation.
    Maehara Y, Emi Y, Anai H, Sakaguchi Y, Kohnoe S, Tsujitani S, Sugimachi K.
    J Pathol; 1989 Dec 01; 159(4):323-7. PubMed ID: 2614577
    [Abstract] [Full Text] [Related]

  • 5. Direct correlation between DNA topoisomerase II activity and cytotoxicity in adriamycin-sensitive and -resistant P388 leukemia cell lines.
    Deffie AM, Batra JK, Goldenberg GJ.
    Cancer Res; 1989 Jan 01; 49(1):58-62. PubMed ID: 2535693
    [Abstract] [Full Text] [Related]

  • 6. Intracellular adriamycin levels and cytotoxicity in adriamycin-sensitive and adriamycin-resistant P388 mouse leukemia cells.
    Ganapathi R, Reiter W, Krishan A.
    J Natl Cancer Inst; 1982 Jun 01; 68(6):1027-32. PubMed ID: 6953267
    [Abstract] [Full Text] [Related]

  • 7. Mechanism of acquired resistance to methotrexate in P388 murine leukemia cells and in their doxorubicin-resistant subline.
    Ramu N, Ramu A, Cole DE, Balis FM, Poplack DG, Pollard HB.
    Isr J Med Sci; 1988 Jun 01; 24(9-10):477-82. PubMed ID: 2974448
    [Abstract] [Full Text] [Related]

  • 8. Enhancement of sensitivity to adriamycin in resistant P388 leukemia by the calmodulin inhibitor trifluoperazine.
    Ganapathi R, Grabowski D.
    Cancer Res; 1983 Aug 01; 43(8):3696-9. PubMed ID: 6861140
    [Abstract] [Full Text] [Related]

  • 9. DNA breakage in human lung carcinoma cells and nuclei that are naturally sensitive or resistant to etoposide and teniposide.
    Long BH, Musial ST, Brattain MG.
    Cancer Res; 1986 Aug 01; 46(8):3809-16. PubMed ID: 3015377
    [Abstract] [Full Text] [Related]

  • 10. Differential effect of collaterally sensitive antimetabolites on P388 murine leukemia sensitive and resistant to adriamycin in vitro.
    Satyamoorthy K, Deshpande SS, Chitnis MP.
    Neoplasma; 1989 Aug 01; 36(6):673-83. PubMed ID: 2515459
    [Abstract] [Full Text] [Related]

  • 11. In vivo characteristics of resistance and cross-resistance of an adriamycin-resistant subline of P388 leukemia.
    Johnson RK, Chitnis MP, Embrey WM, Gregory EB.
    Cancer Treat Rep; 1978 Oct 01; 62(10):1535-47. PubMed ID: 709555
    [Abstract] [Full Text] [Related]

  • 12. Active efflux of daunorubicin and adriamycin in sensitive and resistant sublines of P388 leukemia.
    Inaba M, Kobayashi H, Sakurai Y, Johnson RK.
    Cancer Res; 1979 Jun 01; 39(6 Pt 1):2200-3. PubMed ID: 445418
    [Abstract] [Full Text] [Related]

  • 13. Modulation of in vitro chemosensitivity by extracellular Ca++ in adriamycin sensitive and resistant P388 leukemic cells.
    Adwankar MK, Chitnis MP.
    Neoplasma; 1990 Jun 01; 37(1):31-6. PubMed ID: 2320178
    [Abstract] [Full Text] [Related]

  • 14. Role of DNA breakage in cytotoxicity of doxorubicin, 9-deoxydoxorubicin, and 4-demethyl-6-deoxydoxorubicin in murine leukemia P388 cells.
    Capranico G, De Isabella P, Penco S, Tinelli S, Zunino F.
    Cancer Res; 1989 Apr 15; 49(8):2022-7. PubMed ID: 2702645
    [Abstract] [Full Text] [Related]

  • 15. Characterization of a subline of P388 leukemia resistant to amsacrine: evidence of altered topoisomerase II function.
    Per SR, Mattern MR, Mirabelli CK, Drake FH, Johnson RK, Crooke ST.
    Mol Pharmacol; 1987 Jul 15; 32(1):17-25. PubMed ID: 3037302
    [Abstract] [Full Text] [Related]

  • 16. Characterization of a DNA topoisomerase IIalpha gene rearrangement in adriamycin-resistant P388 leukemia: expression of a fusion messenger RNA transcript encoding topoisomerase IIalpha and the retinoic acid receptor alpha locus.
    McPherson JP, Brown GA, Goldenberg GJ.
    Cancer Res; 1993 Dec 15; 53(24):5885-9. PubMed ID: 8261398
    [Abstract] [Full Text] [Related]

  • 17. Modulation of doxorubicin-induced DNA lesions by verapamil, DMDP and dipyridamole in resistant P388 cell lines.
    Yin MB, Bankusli I, Frank C, Rustum YM.
    Anticancer Res; 1990 Dec 15; 10(2A):327-32. PubMed ID: 2346306
    [Abstract] [Full Text] [Related]

  • 18. Differences in lipid composition of doxorubicin-sensitive and -resistant P388 cells.
    Ramu A, Glaubiger D, Weintraub H.
    Cancer Treat Rep; 1984 Apr 15; 68(4):637-41. PubMed ID: 6713419
    [Abstract] [Full Text] [Related]

  • 19. In vitro cytotoxicity, cellular pharmacology, and DNA lesions induced by annamycin, an anthracycline derivative with high affinity for lipid membranes.
    Ling YH, Priebe W, Yang LY, Burke TG, Pommier Y, Perez-Soler R.
    Cancer Res; 1993 Apr 01; 53(7):1583-9. PubMed ID: 8453627
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.